• Report SKU:SKU: SYNR9612
  • Description
  • Table of Contents
  • Request Sample

The Global Drug Discovery Informatics market is expected to reach $4.26 billion by 2026 growing at a CAGR of 11.3% during 2019 to 2026. Drug discovery informatics enables the users to address a large volume of data storage & management and processing & analyzing the obtained results. These drug discovery informatics platforms employ bioinformatics algorithms for processing life science data and use different in silico models for analyzing the data obtained. Factors such as growing command and support for rare disease and orphan drug research and better research expenditure on informatics by the pharmaceutical and biotechnology industries are driving the market growth. However, the high setup cost of informatics software is restraining the market. Moreover, growth in emerging markets and increasing biotechnology industry and biologics marketplace in informatics drug discovery is creating ample opportunities across the globe. Based on end user, the pharmaceutical companies segment is going to have a lucrative growth due to using informatics software widely for pre-clinical research & development, target identification, compound screening, and lead identification, and streamlining their drug discovery process. The key vendors mentioned are Certara, L.P., Charles River , Collaborative Drug Discovery, Inc., IBM, Infosys Limited, Jubilant Life Sciences Ltd., PerkinElmer Inc., Schrodinger, LLC, Thermo Fisher Scientific Inc., Novo Informatics, Dassault Systemes , Selvita, GVK Biosciences, Openeye Scientific Software and IO Informatics. Solutions Covered: • Services • Software Functions Covered: • Docking • Library & Database Preparation • Molecular Modelling • Sequencing and Target Data Analysis • Lead Generation Informatics • Identification & Validation Informatics • Screening and ADMET characterization • Clinical Trial Data Management Modes Covered: • In-house Informatics • Outsourced Informatics Modalities Covered: • In-campus Platform • Cloud-based Systems Applications Covered: • Drug Development • Drug Discovery End Users Covered: • Biotechnology Companies • Contract Research Organization (CROs) • Pharmaceutical Companies • Research Institutes Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2018 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Drug Discovery Informatics Market, By Solution
5.1 Introduction
5.2 Services
5.3 Software

6 Global Drug Discovery Informatics Market, By Function
6.1 Introduction
6.2 Docking
6.3 Library & Database Preparation
6.4 Molecular Modelling
6.5 Sequencing and Target Data Analysis
6.6 Lead Generation Informatics
6.7 Identification & Validation Informatics
6.8 Screening and ADMET characterization
6.9 Clinical Trial Data Management

7 Global Drug Discovery Informatics Market, By Mode
7.1 Introduction
7.2 In-house Informatics
7.3 Outsourced Informatics

8 Global Drug Discovery Informatics Market, By Modality
8.1 Introduction
8.2 In-campus Platform
8.3 Cloud-based Systems

9 Global Drug Discovery Informatics Market, By Application
9.1 Introduction
9.2 Drug Development
9.3 Drug Discovery

10 Global Drug Discovery Informatics Market, By End User
10.1 Introduction
10.2 Biotechnology Companies
10.3 Contract Research Organization (CROs)
10.4 Pharmaceutical Companies
10.5 Research Institutes

11 Global Drug Discovery Informatics Market, By Geography
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 South America
11.6 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape
13.1 Certara, L.P.
13.2 Charles River
13.3 Collaborative Drug Discovery, Inc.
13.4 IBM
13.5 Infosys Limited
13.6 Jubilant Life Sciences Ltd.
13.7 PerkinElmer Inc.
13.8 Schrodinger, LLC
13.9 Thermo Fisher Scientific Inc.
13.10 Novo Informatics
13.11 Dassault Systemes
13.12 Selvita
13.13 GVK Biosciences
13.14 Openeye Scientific Software
13.15 IO Informatics

List of Data Tables
Table 1 Global Drug Discovery Informatics Market Outlook, By Region (2018-2026) ($MN)
Table 2 Global Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 3 Global Drug Discovery Informatics Market Outlook, By Services (2018-2026) ($MN)
Table 4 Global Drug Discovery Informatics Market Outlook, By Software (2018-2026) ($MN)
Table 5 Global Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 6 Global Drug Discovery Informatics Market Outlook, By Docking (2018-2026) ($MN)
Table 7 Global Drug Discovery Informatics Market Outlook, By Library & Database Preparation (2018-2026) ($MN)
Table 8 Global Drug Discovery Informatics Market Outlook, By Molecular Modelling (2018-2026) ($MN)
Table 9 Global Drug Discovery Informatics Market Outlook, By Sequencing and Target Data Analysis (2018-2026) ($MN)
Table 10 Global Drug Discovery Informatics Market Outlook, By Lead Generation Informatics (2018-2026) ($MN)
Table 11 Global Drug Discovery Informatics Market Outlook, By Identification & Validation Informatics (2018-2026) ($MN)
Table 12 Global Drug Discovery Informatics Market Outlook, By Screening and ADMET characterization (2018-2026) ($MN)
Table 13 Global Drug Discovery Informatics Market Outlook, By Clinical Trial Data Management (2018-2026) ($MN)
Table 14 Global Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 15 Global Drug Discovery Informatics Market Outlook, By In-house Informatics (2018-2026) ($MN)
Table 16 Global Drug Discovery Informatics Market Outlook, By Outsourced Informatics (2018-2026) ($MN)
Table 17 Global Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 18 Global Drug Discovery Informatics Market Outlook, By In-campus Platform (2018-2026) ($MN)
Table 19 Global Drug Discovery Informatics Market Outlook, By Cloud-based Systems (2018-2026) ($MN)
Table 20 Global Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 21 Global Drug Discovery Informatics Market Outlook, By Drug Development (2018-2026) ($MN)
Table 22 Global Drug Discovery Informatics Market Outlook, By Drug Discovery (2018-2026) ($MN)
Table 23 Global Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)
Table 24 Global Drug Discovery Informatics Market Outlook, By Biotechnology Companies (2018-2026) ($MN)
Table 25 Global Drug Discovery Informatics Market Outlook, By Contract Research Organization (CROs) (2018-2026) ($MN)
Table 26 Global Drug Discovery Informatics Market Outlook, By Pharmaceutical Companies (2018-2026) ($MN)
Table 27 Global Drug Discovery Informatics Market Outlook, By Research Institutes (2018-2026) ($MN)
Table 28 North America Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 29 North America Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 30 North America Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 31 North America Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 32 North America Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 33 North America Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)
Table 34 Europe Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 35 Europe Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 36 Europe Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 37 Europe Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 38 Europe Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 39 Europe Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)
Table 40 Asia Pacific Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 41 Asia Pacific Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 42 Asia Pacific Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 43 Asia Pacific Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 44 Asia Pacific Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 45 Asia Pacific Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)
Table 46 South America Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 47 South America Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 48 South America Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 49 South America Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 50 South America Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 51 South America Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)
Table 52 Middle East & Africa Drug Discovery Informatics Market Outlook, By Solution (2018-2026) ($MN)
Table 53 Middle East & Africa Drug Discovery Informatics Market Outlook, By Function (2018-2026) ($MN)
Table 54 Middle East & Africa Drug Discovery Informatics Market Outlook, By Mode (2018-2026) ($MN)
Table 55 Middle East & Africa Drug Discovery Informatics Market Outlook, By Modality (2018-2026) ($MN)
Table 56 Middle East & Africa Drug Discovery Informatics Market Outlook, By Application (2018-2026) ($MN)
Table 57 Middle East & Africa Drug Discovery Informatics Market Outlook, By End User (2018-2026) ($MN)